UBS Group AG

Position in YARW — Yarrow Bioscience, Inc.

CIK 1610520 ZURICH, V8

Position in YARW

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$38,146

-$69,364 QoQ

Shares Held

1,172

-67.4% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#20

of 44 holders

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. YARW ranks #403 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,450,825	$1,020,369,609
2	ROIV	Roivant Sciences Ltd.	17,466,641	$618,144,423
3	PTGX	Protagonist Therapeutics, Inc	3,399,221	$416,676,508
4	VRTX	Vertex Pharmaceuticals Inc / Ma	712,259	$353,800,411
5	MRNA	Moderna, Inc.	4,463,211	$312,558,664
6	INSM	INSMED Inc	2,584,446	$275,553,630
7	ABVX	Abivax S.A.	1,844,918	$245,853,771
8	MDGL	Madrigal Pharmaceuticals, Inc.	401,708	$215,697,109

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$38,146	58,597	-67.4%	Shares	Defined	2026-08-13
2026-03-31	$107,510	179,784	+186.5%	Shares	Defined	2026-05-05
2025-12-31	$36,401	62,761	+1026.4%	Shares	Defined	2026-01-29
2025-09-30	$1,866	5,572	-26.5%	Shares	Defined	2025-11-13
2025-03-31	$11,970	7,576	+1100.6%	Shares	Defined	2025-05-13
2024-12-31	$2,113	631	+4407.1%	Shares	Sole	2025-02-14
2024-09-30	$26	14	-99.9%	Shares	Sole	2024-11-14
2024-06-30	$49,363	25,058	+156512.5%	Shares	Defined	2024-08-14
2024-03-31	$48	16	-98.1%	Shares	Defined	2024-05-13
2023-12-31	$1,969	846	+359.8%	Shares	Defined	2024-02-09
2023-09-30	$742	184	-83.1%	Shares	Sole	2023-11-09
2023-06-30	$4,452	1,086	+197.5%	Shares	Sole	2023-08-11
2023-03-31	$1,124	365	—	Shares	Defined	2023-05-12
No filing history on record for this holder in this stock.